ALFA FinderBSE filing, NSE: STYRENIX. Summary written from the filing by ALFA Finder's alert engine.
Styrenix Performance Materials Ltd: key numbers
- Share price
- ₹1,850.50
- Market cap
- ₹3,254 Cr
- Revenue (annual)
- ₹3,438 Cr
- Net profit (annual)
- ₹182.8 Cr
- P/E (TTM)
- 12.9×Sector 28.2×
- Promoter holding
- 46.24%+0.00% QoQ
- FII holding
- 1.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Styrenix Performance Materials Ltd
All →Styrenix Performance Materials Capital Structure Change
Bandhan Mutual Fund lifted its Styrenix stake to 5.0062% via 15,000 open-market shares bought on October 29, 2026. The non-promoter SAST disclosure states no transaction value.
Styrenix Performance Materials Earnings Call Transcript: Key Takeaways
Strong standalone revenue growth of 26.5% YoY is severely diluted by structural losses in Thailand. Management is prioritizing high-margin specialized ABS grades while defensively reducing exposure to volatile, commoditized polystyrene volumes.
Styrenix Performance Materials Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹993.5cr (+24.4%) but PAT fell 48.2% to ₹23.2cr; standalone PAT ₹51.2cr (+0.8%). Consolidated EBITDA margin compressed to 7.6%.
Styrenix Performance Materials Q2 FY27 Results: Net Profit ₹23.2 Cr, Down 48.1% YoY
Styrenix Performance Materials Ltd reported revenue from operations of ₹993.5 Cr (+24.4% YoY) and net profit of ₹23.2 Cr (-48.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹23.2 Cr · -48.1% YoY
Styrenix Performance Materials Board Meeting Date
Styrenix Performance Materials Ltd scheduled a board meeting for October 28, 2026, to consider and approve standalone and consolidated unaudited financial results.
Styrenix Performance Materials Other Announcement
Styrenix Performance Materials Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026. This disclosure adheres to Regulation 31(1)(b) of SEBI LODR.
Other business update announcements
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years
Msafe Equipments Business Update
MSAFE Equipments announced a Dhanteras puja at its upcoming Mathura integrated manufacturing facility, expected to commence operations by May 2027. The release describes planned capacity expansion but reports no contract, order, or financial value.
Skyways Air Services Business Update
Skyways Air Services renewed its Global Annual Agreement with Qatar Airways for one year. The agreement's size is not quantifiable, so no value is assigned.
- From
- Qatar Airways Group Q.C.S.C.
- Execution
- 1 year from effective date 1 January 2026
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.